Jackson Scott Thomas 4
Research Summary
AI-generated summary
Macrogenics (MGNX) Director Jackson Thomas Exercises Options, Receives RSUs
What Happened
Director Jackson Scott Thomas executed a set of derivative and equity-award transactions reported for May 18–19, 2026. The filing shows an exercise/conversion of 3,750 derivative shares on May 18 (an acquired block) and a simultaneous disposition of 3,750 shares at $0.00 the same day (no cash proceeds reported). On May 19 he was reported as receiving two awards/grants totaling 25,750 RSUs (3,750 and 22,000 RSUs) at $0.00. No open‑market sales or cash purchases are reported.
Key Details
- Filing date: May 20, 2026; Transaction dates: May 18–19, 2026. No late filing is indicated in the supplied data.
- Exercise/conversion (code M): 3,750 shares acquired (5/18); 3,750 shares disposed at $0.00 (5/18).
- Awards/grants (code A): 3,750 RSUs and 22,000 RSUs granted on 5/19 (both reported at $0.00).
- Total RSUs reported awarded: 25,750. No dollar values or proceeds reported.
- Shares owned after the transactions: not specified in the provided filing details.
- Footnotes of note:
- RSUs represent a contingent right to one share each (F1).
- Some RSUs vested on May 18, 2026 (F2); other RSUs vest one year after grant or the day prior to the next annual meeting, if earlier (F3).
- Option vesting schedule noted as monthly 1/12th increments beginning one month after grant (F4).
Context
The zero-dollar disposition is consistent with shares being surrendered/withheld (tax withholding or net settlement) rather than an open-market sale; the filing does not show any market sale proceeds. The awards are RSUs, which convert into shares according to the vesting rules above and do not necessarily indicate a purchase decision. For retail investors, awards and option exercises are common forms of executive compensation and do not by themselves signal a buying conviction; purchases or open-market sales are typically more informative about sentiment.